Creative Planning Invitae Corp Transaction History

Creative Planning

$90.1 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.72 $9,389 - $16,097	-22,357 Reduced 55.18%	18,163 $11,000
Q3 2023 Nov 16, 2023	SELL	$0.6 - $1.53 $34,276 - $87,405	-57,128 Reduced 58.5%	40,520 $24,000
Q2 2023 Jul 21, 2023	BUY	$1.05 - $1.63 $15,631 - $24,265	14,887 Added 17.99%	97,648 $110,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $2,508 - $5,705	2,090 Added 2.59%	82,761 $111,000
Q4 2022 Feb 10, 2023	SELL	$1.71 - $3.61 $14,835 - $31,320	-8,676 Reduced 9.71%	80,671 $150,000

Q3 2022 Nov 03, 2022	BUY	$1.9 - $8.63 $14,934 - $67,831	7,860 Added 9.65%	89,347 $220,000
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $55,654 - $235,422	26,129 Added 47.2%	81,487 $199,000
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $2,976 - $7,389	474 Added 0.86%	55,358 $441,000
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $20,815 - $40,596	-1,416 Reduced 2.52%	54,884 $838,000
Q3 2021 Nov 10, 2021	SELL	$24.31 - $33.6 $30,825 - $42,604	-1,268 Reduced 2.2%	56,300 $1.6 Million
Q2 2021 Aug 04, 2021	SELL	$26.09 - $40.4 $497,379 - $770,185	-19,064 Reduced 24.88%	57,568 $1.94 Million
Q1 2021 Apr 30, 2021	BUY	$33.06 - $56.93 $425,812 - $733,258	12,880 Added 20.2%	76,632 $2.93 Million
Q4 2020 Jan 29, 2021	BUY	$39.09 - $57.4 $86,662 - $127,255	2,217 Added 3.6%	63,752 $2.67 Million
Q3 2020 Nov 05, 2020	BUY	$28.43 - $44.67 $180,672 - $283,877	6,355 Added 11.52%	61,535 $2.67 Million
Q2 2020 Jul 23, 2020	SELL	$11.71 - $30.29 $133,763 - $346,002	-11,423 Reduced 17.15%	55,180 $1.67 Million
Q1 2020 May 05, 2020	BUY	$7.64 - $27.5 $105,072 - $378,207	13,753 Added 26.02%	66,603 $910,000
Q4 2019 Jan 30, 2020	BUY	$15.02 - $20.57 $5,752 - $7,878	383 Added 0.73%	52,850 $852,000
Q2 2019 Jul 26, 2019	BUY	$17.37 - $26.27 $28,921 - $43,739	1,665 Added 3.28%	52,467 $1.23 Million
Q1 2019 Apr 24, 2019	BUY	$10.65 - $25.75 $1,597 - $3,862	150 Added 0.3%	50,802 $1.19 Million
Q4 2018 Feb 01, 2019	SELL	$9.26 - $16.38 $175 - $311	-19 Reduced 0.04%	50,652 $560,000
Q3 2018 Oct 25, 2018	BUY	$7.54 - $18.31 $301 - $732	40 Added 0.08%	50,671 $848,000
Q2 2018 Jul 20, 2018	BUY	$4.87 - $8.42 $555 - $959	114 Added 0.23%	50,631 $372,000
Q4 2017 Jan 17, 2018	BUY	$7.86 - $9.99 $397,063 - $504,664	50,517	50,517 $459,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

7.66M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account